The USP 800 Guidelines have made the compounding of liquid formulations of NIOSH list medications more cumbersome and costly. Many institutions have updated facilities, revised standard operating procedures, and trained staff at much expense in order to continue to offer this service to their patients. For some, the high costs […]
Category: News
Neonatal Clonidine Formulation
Through P&C’s collaboration with Akron Children’s Hospital in Ohio, a new neonatal clonidine formulation has been created using QuartetRx®. The formulation employs 0.3 mg clonidine tablets in water and simple syrup yielding a final concentration of 20 mcg/ml. Formulation and stability data presented at the 2019 ASHP Midyear meeting in […]
QuartetRX® Whole-Capsule Compounding
Exciting new developments in the whole-capsule compounding are on the horizon from P&C’s collaboration with CHU-Sainte Justine in Montréal, Canada. We have embarked on ground-breaking research using whole capsules in the compounding of hazardous drugs. Specifically, the team at CHU-Sainte Justine is exploring the use of QuartetRX in the compounding […]
Dayton innovators: Local man helps patients easily consume medicine
Editors note: Dayton Daily News writer Thomas Gnau is introducing to the public Dayton-area innovators and patent-holders, those who roll up their sleeves and demonstrate that the region remains a cradle of creativity. For full article, please visit link at end of preview. Joe D’Silva, founder of P & C Pharma […]
Science and health booming in Ohio thanks to area companies
Editors Note: The preview of this article was originally posted in the Dayton Business Journal and written by Thomas Gnau. The full article can be viewed using the link at the end of the preview. New health care and biosciences innovations in this region are helping add high-paying jobs and […]